1. Home
  2. ATYR vs FPI Comparison

ATYR vs FPI Comparison

Compare ATYR & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • FPI
  • Stock Information
  • Founded
  • ATYR 2005
  • FPI 2013
  • Country
  • ATYR United States
  • FPI United States
  • Employees
  • ATYR N/A
  • FPI N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • FPI Real Estate Investment Trusts
  • Sector
  • ATYR Health Care
  • FPI Real Estate
  • Exchange
  • ATYR Nasdaq
  • FPI Nasdaq
  • Market Cap
  • ATYR 451.3M
  • FPI 516.0M
  • IPO Year
  • ATYR 2015
  • FPI 2014
  • Fundamental
  • Price
  • ATYR $5.48
  • FPI $11.21
  • Analyst Decision
  • ATYR Strong Buy
  • FPI
  • Analyst Count
  • ATYR 6
  • FPI 0
  • Target Price
  • ATYR $20.20
  • FPI N/A
  • AVG Volume (30 Days)
  • ATYR 3.6M
  • FPI 473.3K
  • Earning Date
  • ATYR 08-12-2025
  • FPI 07-23-2025
  • Dividend Yield
  • ATYR N/A
  • FPI 2.10%
  • EPS Growth
  • ATYR N/A
  • FPI 104.48
  • EPS
  • ATYR N/A
  • FPI 1.09
  • Revenue
  • ATYR N/A
  • FPI $56,535,000.00
  • Revenue This Year
  • ATYR $960.85
  • FPI N/A
  • Revenue Next Year
  • ATYR $1,283.47
  • FPI N/A
  • P/E Ratio
  • ATYR N/A
  • FPI $10.53
  • Revenue Growth
  • ATYR N/A
  • FPI N/A
  • 52 Week Low
  • ATYR $1.48
  • FPI $9.66
  • 52 Week High
  • ATYR $5.98
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 56.44
  • FPI 48.15
  • Support Level
  • ATYR $4.96
  • FPI $11.43
  • Resistance Level
  • ATYR $5.45
  • FPI $11.69
  • Average True Range (ATR)
  • ATYR 0.36
  • FPI 0.17
  • MACD
  • ATYR -0.06
  • FPI -0.05
  • Stochastic Oscillator
  • ATYR 60.42
  • FPI 7.71

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: